CytoMed Therapeutics Limited Ordinary Shares
Quarterly Financials
| Values in thousands | 2024-03-31 | 2023-09-30 |
|---|---|---|
Revenue | $84 | $81 |
Gross Profit | 83 | 80 |
EBITDA | -620 | -598 |
EBIT | -687 | -663 |
Net Income | -748 | -722 |
Net Change In Cash | 84 | 81 |
Free Cash Flow | -545 | -526 |
Cash | 8,995 | 8,995 |
Basic Shares | 11,540 | 11,540 |
Annual Financials
| Values in thousands | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 |
|---|---|---|---|---|
Revenue | $384 | $363 | $113 | $59 |
Gross Profit | 381 | 355 | 110 | 54 |
EBITDA | -2,624 | -1,495 | -1,607 | -963 |
EBIT | -2,911 | -1,888 | -1,937 | -1,256 |
Net Income | -3,131 | -3,227 | -2,074 | -1,942 |
Net Change In Cash | 384 | 363 | 113 | 59 |
Free Cash Flow | -3,491 | -1,872 | -2,295 | -1,114 |
Cash | 8,995 | 1,579 | 2,512 | 885 |
Basic Shares | 10,630 | 7,915 | 6,934 | 5,897 |
Earnings Calls
| Quarter | EPS |
|---|---|
2024-03-31 | $0 |
2023-12-31 | $0 |
2023-09-30 | -$0.08 |
2023-06-30 | -$0.06 |
